Inovio Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Inovio Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Inovio Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Inovio Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Inovio Pharmaceuticals Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Inovio Pharmaceuticals Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Simon X. Benito
Chairman Executive BoardMr. Simon X. Benito has been the Chairman of the company since 2019. Prior to this, he served as the Director of Inovio since 2003. Mr. Benito held various leadership positions at Merck & Co. including Senior Vice President of Merck Vaccine Division and Vice President of Merck Human Health for Japan. Mr. Benito also served as Executive Vice President of Merck-Medco Managed Care.
Jacqueline E. Shea, PhD
Chief Executive Officer; President; Director Executive BoardMs. Jacqueline E. Shea has been the President, Director and Chief Executive Officer of the company since 2022. Prior to this she served as the Chief Operating Officer of the company from March 2019 to May 2022. Previously, she served as the Chief Executive Officer of Aeras. Ms. Shea also served as the Chief Operating Officer of Aeras, General Manager and Vice President of The Oxford-Emergent Tuberculosis Consortium at Emergent BioSolutions.
Peter D. Kies
Chief Financial Officer Senior ManagementMr. Peter D. Kies has been the Chief Financial Officer of the company since 2002. Prior to this, he served as the Chief Financial Officer at Newgen Results Corporation. Mr. Kies held various financial positions at Cytel Corporation and Ernst & Young, LLP.
Rob Crotty
Secretary; General Counsel; Chief Compliance Officer Senior ManagementMr. Rob Crotty has been the Chief Compliance Officer, Corporate Secretary, and General Counsel of the company since 2021. Prior to this, he served in various leadership roles at ImClone Systems Incorporated, NPS Pharmaceuticals, Dendron Corporation, Vernalis Therapeutics, and Nabriva Therapeutics.
Michael Sumner, MD
Head - Development; Chief Medical Officer Senior ManagementDr. Michael Sumner has been the Chief Medical Officer of the company since 2022. Prior to this, he served as the Chief Medical Officer of Orexo AB from 2013 to 2022. Previously, he held Novartis Pharmaceuticals, Aventis Behring, Novo Nordisk and Shire Pharmaceuticals.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer